ID: 903
Titel: A Randomized Phase 2 Study of Adjunctive EQU-001 for Uncontrolled Focal Onset Seizures
Provsamlingsansvarig: JOhan Zelano
Start insamling: 2022-03-01
Slut insamling: 2035-06-30
Beskrivning: The objective of this Phase 2, controlled, randomized, double blind study with an open-label extension (OLE) is to 
evaluate the efficacy, safety and tolerability of adjunctive EQU-001 compared with placebo for the treatment of focal 
onset seizures in subjects aged 18-65 years. The primary endpoint is the median percentage change in seizure 
frequency per 28 days in the double-blind period as compared with the baseline period in each treatment group. The 
entire duration of the study is approximately 52 months

PROVTYP;PROVGIVARE
Blod(3.0-8.0 ml per sample);20
Blood (sreen failure);7
Urine (10 ml per sample);20
Urine(screen failure);7